Cipla Europe NV G.L. Pharma GmbH S&D Pharma CZ, spol. s.r.o.
PolandAll medications by this manufacturer
-
Fullhale ciphaler
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.25 mg ATC: R03AK06
-
Fullhale ciphaler
Form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 0.0725 mg fluticasone propionate 0.5 mg ATC: R03AK06